Columnist Laura Thissen is not saying that CRISPR is a panacea, but it can be a contributing factor in feeding 8 billion mouths. When does Europe feel the urge?
Columnist Laura Thissen
It’s been four long years since the European Court of Justice ruled that CRISPR-Cas should be treated as genetically modified crops. In the meantime, the super specific genetic scissor won the 2020 Nobel Prize, and has the potential to unlock unlimited possibilities: to make maize varieties resistant to climate change and tomatoes untouched by diseases.
But you won’t find any of these products in European supermarkets.
Numerous innovative young companies use CRISPR to put new crops on the market. Very few of them in Europe – for the simple reason that they cannot enter the European market. In the past 5 years the US proved a fertile ground for these innovative companies – and Europe is missing out.
The US treats CRISPR crops equal if those crops could also have been the result of traditional crop breeding. US-based CRISPR startups are popping out of the ground due to this accommodating regulatory framework. North Carolina-based and Bayer-backed biotech company Pairwise already bagged 115 million dollar to boost its gene-editing creation of new fruit and vegetable varieties for the US market.
Along the same line of thinking as in the US, post-Brexit UK is moving to regulatory approval of CRISPR crops, if the final product could also have seen the light through natural selection.
The differences between conventional breeding and genetic engineering are not so clear cut anymore. Last month, researchers in Science called for regulation to assess the crop variety rather than the technology. Their argument: it doesn’t make any sense anymore to look at the tech, what’s important is that the crop variety is screened on safety.
Europe will continue to miss out if the regulatory framework is not adjusted. The EU’s public consultation closed last summer, and the EU is now reviewing its 71,000 responses. In the second quarter of 2023, the EU will conclude if the current regulatory framework fits CRISPR.
I’m not saying that CRISPR is a panacea, but it can be a contributing factor in feeding 8 billion mouths. CRISPR can adjust crops to withstand changing climates, and fast too. As COP 27 laid bare that keeping global warming below 1.5C is unattainable, now it’s even more urgent than ever.
Let’s hope 2023 will be the year of CRISPR.
Laura Thissen has over 15 years experience in business development for sustainable innovations contributing to the transition to sustainable food systems and a biobased economy. She writes on her own behalf on sustainability, innovative technology, and startups.
